46 related articles for article (PubMed ID: 20560860)
1. Precancerous lesion determinants in women attending cervical cancer screening at public health facilities in North Shoa Zone, Amhara, Ethiopia: an unmatched case-control study.
Teklehaimanot DA; Mekuria AD; Dadi AF; Derseh BT
BMC Womens Health; 2024 May; 24(1):271. PubMed ID: 38702683
[TBL] [Abstract][Full Text] [Related]
2. Nationwide Rereview of Normal Cervical Cytologies before High-Grade Cervical Lesions or before Invasive Cervical Cancer.
Edvardsson H; Wang J; Andrae B; Sparén P; Strander B; Dillner J
Acta Cytol; 2021; 65(5):377-384. PubMed ID: 34077926
[TBL] [Abstract][Full Text] [Related]
3. Cervical cancer risk factors among HIV-infected Nigerian women.
Ononogbu U; Almujtaba M; Modibbo F; Lawal I; Offiong R; Olaniyan O; Dakum P; Spiegelman D; Blattner W; Adebamowo C
BMC Public Health; 2013 Jun; 13():582. PubMed ID: 23767681
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda.
Makuza JD; Nsanzimana S; Muhimpundu MA; Pace LE; Ntaganira J; Riedel DJ
Pan Afr Med J; 2015; 22():26. PubMed ID: 26664527
[TBL] [Abstract][Full Text] [Related]
5. Fighting cervical cancer in Africa: a cross-sectional study on prevalence and risk factors for precancerous lesions in rural Uganda.
Christensen AJ; Mwayi J; Mbabazi J; Juncker M; Kallestrup P; Kraef C
Public Health; 2023 Dec; 225():87-95. PubMed ID: 37922591
[TBL] [Abstract][Full Text] [Related]
6. Psychiatric morbidity and cervical cancer screening: a retrospective population-based case-cohort study.
Ouk M; Edwards JD; Colby-Milley J; Kiss A; Swardfager W; Law M
CMAJ Open; 2020; 8(1):E134-E141. PubMed ID: 32161045
[TBL] [Abstract][Full Text] [Related]
7. Managing an extension of screening intervals: Avoiding boom and bust in health care workloads.
Pesola F; Rebolj M; Sasieni P
Int J Cancer; 2023 May; 152(10):2061-2068. PubMed ID: 36691808
[TBL] [Abstract][Full Text] [Related]
8. How to evaluate emerging technologies in cervical cancer screening?
Arbyn M; Ronco G; Cuzick J; Wentzensen N; Castle PE
Int J Cancer; 2009 Dec; 125(11):2489-96. PubMed ID: 19626591
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of cervical cancer screening at age 65 - A register-based cohort study.
Pankakoski M; Anttila A; Sarkeala T; Heinävaara S
PLoS One; 2019; 14(3):e0214486. PubMed ID: 30913262
[TBL] [Abstract][Full Text] [Related]
10. Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test.
Kyrgiou M; Kalliala IE; Mitra A; Fotopoulou C; Ghaem-Maghami S; Martin-Hirsch PP; Cruickshank M; Arbyn M; Paraskevaidis E
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD009836. PubMed ID: 28125861
[TBL] [Abstract][Full Text] [Related]
11. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
12. Intensified screening among high risk women within the organised screening programme for cervical cancer in Finland.
Kotaniemi-Talonen L; Malila N; Anttila A; Nieminen P; Hakama M
Acta Oncol; 2011 Jan; 50(1):106-11. PubMed ID: 20560860
[TBL] [Abstract][Full Text] [Related]
13. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
[TBL] [Abstract][Full Text] [Related]
14. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
[TBL] [Abstract][Full Text] [Related]
15. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
